http://www.xconomy.com/san-diego/2009/04/23/investors-dump-anadys-shares-on-report-of-itchy-side-effect/ Business + Technology in the Exponential Economy Sun, 22 Nov 2009 23:52:13 -0600 http://wordpress.org/?v=2.8.6 hourly 1 http://www.xconomy.com/san-diego/2009/04/23/investors-dump-anadys-shares-on-report-of-itchy-side-effect/comment-page-1/#comment-63829 Update: Anadys Partnering Out, Raises $16M to Stay Afloat | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes Sneaky Thu, 04 Jun 2009 15:28:42 +0000 http://www.xconomy.com/?p=21581#comment-63829 [...] shares have been tanking the last two months, ever since EASL data failed to impress investors. Though ANA598 was able lower viral titers, 3/24 healthy volunteers dropped out of the study after [...] [...] shares have been tanking the last two months, ever since EASL data failed to impress investors. Though ANA598 was able lower viral titers, 3/24 healthy volunteers dropped out of the study after [...]

]]> http://www.xconomy.com/san-diego/2009/04/23/investors-dump-anadys-shares-on-report-of-itchy-side-effect/comment-page-1/#comment-63828 Anadys Axes 20 Employees, No Word on Partnering Progress | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Research, Humor and Updates on the Latest Events in Biotech and Pharma - Unique, Insightful, Truthful, Sometimes Sneaky Thu, 04 Jun 2009 14:53:53 +0000 http://www.xconomy.com/?p=21581#comment-63828 [...] shares have been tanking the last two months, ever since EASL data failed to impress investors. Though ANA598 was able lower viral titers, 3/24 healthy volunteers dropped out of the study after [...] [...] shares have been tanking the last two months, ever since EASL data failed to impress investors. Though ANA598 was able lower viral titers, 3/24 healthy volunteers dropped out of the study after [...]

]]>